Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC
- Status
- COMPLETED
- Phase
- PHASE2
GFRα4 CAR T Cells in MTC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
ATG-010(Selinexor) in Combination With Chemotherapy in RRMM
- Status
- RECRUITING
- Phase
- PHASE2
Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Itacitinib for the Prevention of Graft Versus Host Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE2
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
DALY II USA/ MB-CART2019.1 for DLBCL
- Status
- RECRUITING
- Phase
- PHASE2